+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Influence of propylthiouracil and methimazole pre-treatment on the outcome of iodine-131 therapy in hyperthyroid patients with Graves' disease



Influence of propylthiouracil and methimazole pre-treatment on the outcome of iodine-131 therapy in hyperthyroid patients with Graves' disease



Journal of International Medical Research 37(2): 576-582



There is ongoing controversy about potential differences in the influence of the anti-thyroid drugs propylthiouracil (PTU) and methimazole (MMI) on radioiodine treatment of Graves' hyperthyroidism. This retrospective study investigated the influence of PTU and MMI pre-treatment, individually or sequentially, on the outcome of iodine-131 ((131)I) therapy in 199 patients with Graves' disease who had been treated with (131)I for the first time and followed up at 3 and 6 months after treatment. Pre-treatment with PTU, or sequential PTU and MMI pre-treatment, increased the failure rate of (131)I therapy and reduced the rate of hypothyroidism. MMI pre-treatment alone had no significant influence on the results of (131)I therapy. Logistic regression analyses indicated that PTU pre-treatment and having a thyroid gland of > 60 g were both significantly related to (131)I therapy failure.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 053848382

Download citation: RISBibTeXText

PMID: 19383254

DOI: 10.1177/147323000903700235


Related references

Influence of methimazole and radioactive iodine treatment in the serum levels of the chemokine CXCL10 in hyperthyroid patients with Graves' disease. Hormone and Metabolic Research 43(3): 194-199, 2011

The iodine perchlorate discharge test before and after one year of methimazole treatment of hyperthyroid Graves' disease. Journal of Clinical Endocrinology and Metabolism 78(3): 795-799, 1994

Comparison of methimazole, methimazole and sodium ipodate, and methimazole and saturated solution of potassium iodide in the early treatment of hyperthyroid Graves' disease. Clinical Endocrinology 28(3): 305-314, 1988

Comparison of efficacy and adverse effects between methimazole 15 mg+inorganic iodine 38 mg/day and methimazole 30 mg/day as initial therapy for Graves' disease patients with moderate to severe hyperthyroidism. Thyroid 25(1): 43-50, 2015

Metabolism of glucose and glutamine in lymphocytes from Graves' hyperthyroid patients: influence of methimazole treatment. Cell Biochemistry and Function 14(2): 97-104, 1996

Changes of serum cytokines in hyperthyroid Graves' disease patients at diagnosis and during methimazole treatment. Neuroimmunomodulation 18(1): 45-51, 2011

Comparison of methimazole and propylthiouracil in the management of children and adolescents with Graves' disease: efficacy and adverse reactions during initial treatment and long-term outcome. Journal of Pediatric Endocrinology and Metabolism 24(5-6): 257-263, 2011

Propylthiouracil reduces the effectiveness of radioiodine treatment in hyperthyroid patients with Graves' disease. Thyroid 14(7): 525-530, 2004

Iodine prophylaxis intensification. Influence on radioiodine uptake and activity of 131I used in the treatment of hyperthyroid patients with Graves' disease. Nuklearmedizin. Nuclear Medicine 44(5): 197-199, 2006

Effect of methimazole treatment for 2 years on circulating IL-4, IgE, TBII, and TSAb in patients with hyperthyroid Graves' disease. Endocrine Journal 53(6): 783-788, 2006

Adjunctive treatment with propylthiouracil or iodine following radioiodine therapy for Graves' disease. Thyroid 3(4): 269-272, 1993

Thyrotropin receptor antibody activities significantly correlate with the outcome of radioiodine iodine 131 therapy for hyperthyroid graves' disease. Endocrinologia Japonica 38(4): 429-434, 1991

Propylthiouracil versus methimazole in treatment of Graves' disease during pregnancy. Annals of PharmacoTherapy 41(6): 1018-1022, 2007

Treatment with propylthiouracil before radioactive iodine therapy is associated with a higher treatment failure rate than therapy with radioactive iodine alone in Graves' disease. Thyroid 5(4): 243-247, 1995

Successful Re-administration of Low-dose of Methimazole (MMI) in Graves' Disease Patients Who Experienced Allergic Cutaneous Reactions to MMI at Initial Treatment and Had Received Long-term Propylthiouracil (PTU). Internal Medicine 55(22): 3235-3237, 2017